Mode
Text Size
Log in / Sign up
Phase 4 N=100 Randomized Triple-blind Treatment

A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria

Anaesthesia · Cataract

Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Mar 2015
Primary outcome: Primary: Time Taken to Achieve Adequate Akinesia — 41; 41; 9; 9 participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
One-site peribulbar injection (Procedure); Two- site peribulbar injection (Procedure)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
National Eye Centre, Kaduna
Primary completion
Dec 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Time Taken to Achieve Adequate Akinesia
41; 41; 9; 9
PRIMARY
Supplementary Injection(s)
9; 9
PRIMARY
Complications of Local Anaesthetic Injection
1; 0; 0; 1; 0; 14
PRIMARY
Pain Score for Local Anaesthetic Injection
1.64; 1.58
PRIMARY
Pain Score for Cataract Surgery
1.06; 1.06
SECONDARY
Volume of Anaesthetic Drug (ml)
5.36; 5.40
SECONDARY
Total Number of Injections
1.18; 2.18
SECONDARY
Surgeon Satisfaction Score for Local Anaesthetic Block
4; 4
SECONDARY
Acceptability of the Anaesthetic Block to the Subject
50; 50
SECONDARY
Duration of Cataract Surgery (Minutes)
8.78; 8.88

Summary

The aim of the study was to compare the efficacy and safety of single injection peribulbar anaesthesia against the classic double injection technique. This was a double blind randomized controlled trial involving two groups of consenting, adult Nigerian subjects with operable age-related cataract. An anaesthetic nurse who allocated the subjects to the two groups administered all the injections. The same surgeon operated on all the subjects while the principal investigator and a research assistant measured the outcome variables. All others were blinded as to subject allocation.

Eligibility Criteria

Inclusion Criteria

  • Age 50 years and above
  • Diagnosed with uncomplicated senile cataract
  • Visual acuity of <3/60

Exclusion Criteria

  • Impaired mental status
  • Difficulty in speaking
  • Known allergy to amide-type local anaesthetic agents and/ or hyaluronidase
  • Previous surgery in the same eye
  • Glaucoma
  • Impaired ocular motility
  • Eyelid abnormalities
  • Patients with only one eye
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02150460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search